These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 613978)

  • 1. Heterogeneous myocardial responsiveness to antiarrhythmic drugs and its role in their therapeutic action.
    Faucon G; Farges JP; Ollagnier M; Lievre M; Durr F
    Arch Farmacol Toxicol; 1977 Dec; 3(3):189-204. PubMed ID: 613978
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anti-arrhythmia action of combinations of N-propylajmaline bromide with anti-arrhythmia agents of different classes].
    Gendenshteĭn EI; Balashov VP; Kostin IaV; Oleĭnikov VE
    Farmakol Toksikol; 1990; 53(1):30-2. PubMed ID: 1691716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the anti-arrhythmic properties and cardiohemodynamic effects of the basic anti-arrhythmia agents].
    Stoliarchuk AA; Storozhuk BG; Briskin VR
    Farmakol Toksikol; 1985; 48(1):5-10. PubMed ID: 3979536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic activity of Ro-5-5340 in dogs with acute myocardial infarction.
    Yeager HC; Scriabine A; Bellet S
    Arch Int Pharmacodyn Ther; 1968 Oct; 175(2):304-8. PubMed ID: 5702949
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiarrhythmic therapy and survival following myocardial infarction.
    Cowan JC; Coulshed DS; Zaman AG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S92-8. PubMed ID: 1725053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of stirocainide in acute myocardial infarction.
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Hübner G; Dorsel T; Schmidt J
    Arzneimittelforschung; 1984; 34(5):559-62. PubMed ID: 6540572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply].
    Gendenshteĭn EI; Kostin IaV; Markelova NN; Balashov VP; Oleĭnikov VE; Perevarin AV
    Farmakol Toksikol; 1990; 53(4):28-30. PubMed ID: 2226754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential responsiveness to antiarrhythmic drugs in the rabbit atrio-ventricular conducting system.
    Németh M; Papp JG; Szekeres L
    Acta Physiol Hung; 1990; 75 Suppl():223-4. PubMed ID: 2371871
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F
    Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic therapy in post myocardial infarction patients.
    Cowan C; Campbell RW
    Eur Heart J; 1986 May; 7 Suppl A():145-7. PubMed ID: 3720769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Class I anti-arrhythmia agents and prevention of sudden death following myocardial infarction].
    Boissel JP; Lièvre M; Rosenberg Y
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():49-54. PubMed ID: 1669239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should antiarrhythmic drug prophylaxis be routine after acute myocardial infarction?
    Halkin H; Melmon KL
    Ration Drug Ther; 1973 Jun; 7(6):1-5. PubMed ID: 4731079
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary prophylaxis with antiarrhythmic agents in survivors of myocardial infarction.
    Sethi KK; Mohan JC
    Indian Heart J; 1990; 42(6):403-5. PubMed ID: 2098310
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
    Lucchesi BR; Kniffen FJ
    Circulation; 1975 Dec; 52(6 Suppl):III241-7. PubMed ID: 1182977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of atrioventricular tachycardia].
    Seipel L; Kühlkamp V
    Ther Umsch; 1992 Aug; 49(8):536-42. PubMed ID: 1519182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.